featured
Risk Factors for Subretinal Fibrosis After Anti-VEGF Treatment of mCNV
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The British Journal of Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Risk Factors for Subretinal Fibrosis After Anti-VEGF Treatment of Myopic Choroidal Neovascularisation
Br J Ophthalmol 2020 Mar 11;[EPub Ahead of Print], H Xiao, X Zhao, S Li, L Sun, W Xin, Z Wang, A Zhang, J Zhang, X DingFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.